Daewoong Pharmaceutical is a major South Korean pharmaceutical company whose subsidiary Daewoong Bio provides CMO services for biopharmaceutical manufacturing. Daewoong Bio opened a Bio-Center in Hyangnam for end-to-end CMO services and completed a bioplant in Hwaseong for microbial-based drug production. The company is FDA-registered with 5 FEI numbers and has 2 FDA-approved injectable products.
Biopharmaceutical CMO, microbial-based drug manufacturing, injectable production, API manufacture
1 site worldwide
Involvement in 18 clinical trials
No reviews available yet.
No documents available.